O U R W H Y
Transplantation: more than organs
We Engineer Life
Breakthrough technologies are enabling patient-specific therapies to reach those in need. In many cases, editing the cells or genes of patients allow practitioners to avoid traditionally painful and life-diminishing transplantation methods. Our work is focused on serving patients suffering countless disease burdens that can be cured through targeted micro-transplantation.
CAR-T, Gene and Stem-Cell Therapy Are Examples of Modern Micro-Transplantation
A PLATFORM WITH ENDLESS APPLICATIONS
Total Therapy for Countless Illnesses
Despite medical advancements, the greatest diseases humans face have persisted in high rates of death and suffering. To confront these burdens, today’s cutting-edge therapies leverage the unique properties of each patient’s cellular makeup. Our approach, based in non-human embryonic stem cell therapy, has the potential to offer higher quality therapies without the current invasive procedures needed to obtain a patient’s own genes (U.S. Provisional Patent App. No. 16/830,213).
Cardiovascular Disease, Cancer, and Other Leading Causes of Death Can Be Treated with Micro-Transplantation
CELL THERAPY + XENOTRANSPLANTATION
Addressing Unmet Medical Needs
Xenotransplantation is the process of grafting or transplanting organs or tissues between members of different species. The field has historically focused on transplanting solid organs, but we believe engineering life must begin at the cellular level. By combining fundamental principles with proven technologies such as CRISPR/Cas-9, iPSC generation, and FDA-approved techniques for raising genetically engineered donor animals (Patent No. 10,799,614), we are leading the field with revolutionary designs in xenogeneic cell therapiy to address countless diseases.
Xenotransplants Are Higher Quality and Less Invasive Than Standard-of-Care Treatments